Vannucchi, A. M., Verstovsek, S., Guglielmelli, P., Griesshammer, M., Burn, T. C., Naim, A., . . . Kiladjian, J. (2017). Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study. Ann Hematol.
استشهاد بنمط شيكاغوVannucchi, Alessandro Maria, et al. "Ruxolitinib Reduces JAK2 P.V617F Allele Burden in Patients With Polycythemia Vera Enrolled in the RESPONSE Study." Ann Hematol 2017.
MLA استشهادVannucchi, Alessandro Maria, et al. "Ruxolitinib Reduces JAK2 P.V617F Allele Burden in Patients With Polycythemia Vera Enrolled in the RESPONSE Study." Ann Hematol 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.